157
Views
22
CrossRef citations to date
0
Altmetric
Reviews

Effect of bacterial and host factors on Helicobacter pylori eradication therapy

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shadiyeh Khani, Amin Talebi Bezmin Abadi & Ashraf Mohabati Mobarez. (2019) Clarithromycin-Susceptible But Virulent Helicobacter pylori Strains Infecting Iranian Patients’ Stomachs. Infection and Drug Resistance 12, pages 3415-3420.
Read now

Articles from other publishers (21)

Kefang Sun, Yishu Chen, Zhenzhen Wang, Yi Liu, Yue Pan, Xinli Mao, Lei Xu, Chaohui Jin, Ming Chen, Chaohui Yu & Lan Li. (2022) Application of a WeChat-based mini-app as a patient reminder in Helicobacter pylori eradication: a prospective multi-center randomized controlled study. BMC Gastroenterology 22:1.
Crossref
Vladimir I. Simanenkov & Sergei A. Alekseenko. (2022) Prospects for personalized Helicobacter pylori eradication therapy. Pro et contra. Terapevticheskii arkhiv 94:8, pages 935-939.
Crossref
Soledad García-Gómez-Heras, María Jesús Fernández-Aceñero, Gilberto González, María de Lourdes Bolaños-Muñoz, Raquel Franco-Rodríguez, Julio Paredes-González & Jaime Ruiz-Tovar. (2022) Involvement of Helicobacter pylori in Preoperative Gastric Findings on a Bariatric Population. International Journal of Environmental Research and Public Health 19:15, pages 9088.
Crossref
Loan T. T. Le, Tuan A. Nguyen, Nghia A. Nguyen, Yen T. H. Nguyen, Hai T. B. Nguyen, Liem T. Nguyen, Mai T. Vi & Thang Nguyen. (2022) Helicobacter pylori Eradication Efficacy of Therapy Based on the Antimicrobial Susceptibility in Children with Gastritis and Peptic Ulcer in Mekong Delta, Vietnam. Children 9:7, pages 1019.
Crossref
M Nkuize, J Vanderpas, M Buset, M Delforge, G‐B Cadière & S Wit. (2021) Failure to eradicate Helicobacter pylori infection is more frequent among HIV‐positive patients . HIV Medicine 22:7, pages 547-556.
Crossref
Paula Roszczenko-Jasińska, Marta Ilona Wojtyś & Elżbieta K. Jagusztyn-Krynicka. (2020) Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targets. Applied Microbiology and Biotechnology 104:23, pages 9891-9905.
Crossref
Sinem Oktem-Okullu, Zehra Cekic-Kipritci, Elif Kilic, Nogayhan Seymen, Nesteren Mansur-Ozen, Ugur Sezerman & Yesim Gurol. (2020) Analysis of Correlation between the Seven Important Helicobacter pylori ( H . pylori ) Virulence Factors and Drug Resistance in Patients with Gastritis . Gastroenterology Research and Practice 2020, pages 1-7.
Crossref
Javier Alcedo, Marta Gracia, Paula García-Cámara, Carmen Palacín, Sonia Gallego, Cristina Jimeno-Ayllon, Santiago Frago, Isabel Aured & Lara Luzón. (2020) Prospective comparative study between two first-line regimens for Helicobacter pylori eradication: Non-bismuth quadruple versus bismuth quadruple therapy. Gastroenterología y Hepatología 43:6, pages 301-309.
Crossref
Javier Alcedo, Marta Gracia, Paula García-Cámara, Carmen Palacín, Sonia Gallego, Cristina Jimeno-Ayllon, Santiago Frago, Isabel Aured & Lara Luzón. (2020) Prospective comparative study between two first-line regimens for Helicobacter pylori eradication: Non-bismuth quadruple versus bismuth quadruple therapy. Gastroenterología y Hepatología (English Edition) 43:6, pages 301-309.
Crossref
D. T. Dicheva, S. A. Karaulov, D. N. Andreev, O. E. Berezutskaya & N. L. Golovkina. (2020) Efficacy of <i>Helicobacter pylori</i> eradication therapy of infection with omeprazole and rabeprazole in overweight and obese patients. Meditsinskiy sovet = Medical Council:4, pages 100-105.
Crossref
Dan Wang, Qianqian Guo, Yuan Yuan & Yuehua Gong. (2019) The antibiotic resistance of Helicobacter pylori to five antibiotics and influencing factors in an area of China with a high risk of gastric cancer. BMC Microbiology 19:1.
Crossref
A M Veliev, I V Maev, D N Andreev, D T Dicheva, A V Zaborovskii, E G Lobanova & L G Bektemirova. (2019) The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease. Terapevticheskii arkhiv 91:8, pages 28-33.
Crossref
D N Andreev, I V Maev, D T Dicheva, A A Samsonov & E V Partzvania-Vinogradova. (2018) Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study. Terapevticheskii arkhiv 90:8, pages 27-32.
Crossref
Wen Zhong Liu, Yong Xie, Hong Lu, Hong Cheng, Zhi Rong Zeng, Li Ya Zhou, Ye Chen, Jiang Bin Wang, Yi Qi Du & Nong Hua Lu. (2018) Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection . Helicobacter 23:2, pages e12475.
Crossref
Denise E Brennan, Colin Dowd, Colm O’Morain, Deirdre McNamara & Sinéad M Smith. (2018) Can bacterial virulence factors predict antibiotic resistant Helicobacter pylori infection? . World Journal of Gastroenterology 24:9, pages 971-981.
Crossref
I V Maev & D N Andreev. (2017) Molecular genetic predictors of resistance to anti-Helicobacter pylori therapy. Terapevticheskii arkhiv 89:8, pages 5-12.
Crossref
Dan Wang, Qiuping Li, Yuehua Gong & Yuan Yuan. (2017) The association between vacA or cagA status and eradication outcome of Helicobacter pylori infection: A meta-analysis. PLOS ONE 12:5, pages e0177455.
Crossref
Xiwen Geng, Wen Li, Zhenghong Chen, Sizhe Gao, Wei Hong, Xiaoran Ge, Guihua Hou, Zhekai Hu, Yabin Zhou, Beini Zeng, Wenjuan Li, Jihui Jia & Yundong Sun. (2017) The Bifunctional Enzyme SpoT Is Involved in the Clarithromycin Tolerance of Helicobacter pylori by Upregulating the Transporters HP0939, HP1017, HP0497, and HP0471. Antimicrobial Agents and Chemotherapy 61:5.
Crossref
Yan Li, Yundong Sun & Wenchao Wang. (2017) Fractional order dynamics for clarithromycin against helicobacter pylori. Fractional order dynamics for clarithromycin against helicobacter pylori.
D N Andreev, D T Dicheva & I V Maev. (2017) Possibilities for optimization of eradication therapy for Helicobacter pylori infection in modern clinical practice. Terapevticheskii arkhiv 89:2, pages 84-90.
Crossref
Zhao-Chun Chi. (2016) Update on prevention and treatment of Helicobacter pylori infection . World Chinese Journal of Digestology 24:16, pages 2454-2462.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.